Nifty
:
20133.15
Sensex
:
66988.44
36.55 (0.18%)
86.53 (0.13%)
Nifty
Sensex
:
:
20133.15
66988.44
36.55 (0.18%)
86.53 (0.13%)

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :
44/99

BSE: 532815 | NSE: SMSPHARMA

NSE BSE
119.00
29-Nov-2023
  • Open
  • High
  • Low
  • Previous Close
  •  121.15
  •  122.05
  •  118.50
  •  121.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  79210
  •  94.86
  •  140.00
  •  54.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,007.78
  • 32.46
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,250.47
  • 0.25%
  • 2.10

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.32%
  • 2.55%
  • 29.07%
  • FII
  • DII
  • Others
  • 0.6%
  • 0.00%
  • 3.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.05
  • 2.35
  • -2.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.44
  • -9.55
  • -14.75

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -14.86
  • -37.73
  • -60.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.92
  • 12.47
  • 14.41

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.16
  • 1.93
  • 2.21

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.80
  • 11.12
  • 13.88

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Net Sales
166.64
159.43
4.52%
135.34
64.39
110.19%
149.43
60.92
145.29%
148.80
121.25
22.72%
Expenses
138.82
145.87
-4.83%
109.16
65.20
67.42%
126.19
65.36
93.07%
130.29
94.21
38.30%
EBITDA
27.82
13.56
105.16%
26.18
-0.81
-
23.24
-4.44
-
18.51
27.05
-31.57%
EBIDTM
16.69%
8.51%
19.35%
-1.26%
15.55%
-7.29%
12.44%
22.30%
Other Income
0.81
0.61
32.79%
0.51
0.80
-36.25%
1.26
0.43
193.02%
2.21
2.13
3.76%
Interest
5.57
5.24
6.30%
6.32
4.85
30.31%
5.88
4.34
35.48%
5.94
4.75
25.05%
Depreciation
7.90
8.09
-2.35%
7.69
7.93
-3.03%
7.97
7.97
0.00%
8.13
8.10
0.37%
PBT
15.16
0.84
1,704.76%
12.68
-12.79
-
10.63
-16.33
-
6.67
16.33
-59.15%
Tax
3.11
0.11
2,727.27%
3.87
-2.60
-
2.57
-25.23
-
1.39
6.05
-77.02%
PAT
12.05
0.73
1,550.68%
8.81
-10.19
-
8.07
8.90
-9.33%
5.28
10.27
-48.59%
PATM
7.23%
0.46%
6.51%
-15.83%
5.40%
14.61%
3.55%
8.47%
EPS
1.39
-0.24
-
1.10
-1.51
-
0.73
0.73
0.00%
0.44
1.06
-58.49%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Net Sales
600.21
522.05
519.87
563.18
411.95
464.91
464.93
445.49
611.53
199.84
Net Sales Growth
47.84%
0.42%
-7.69%
36.71%
-11.39%
0.00%
4.36%
-27.15%
206.01%
 
Cost Of Goods Sold
356.17
335.81
275.45
340.00
246.36
292.71
289.90
295.85
385.15
109.95
Gross Profit
244.04
186.23
244.43
223.18
165.59
172.20
175.03
149.64
226.38
89.88
GP Margin
40.66%
35.67%
47.02%
39.63%
40.20%
37.04%
37.65%
33.59%
37.02%
44.98%
Total Expenditure
504.46
467.49
405.26
442.04
331.92
374.77
371.59
370.35
522.32
150.38
Power & Fuel Cost
-
36.73
32.58
23.31
18.99
21.75
22.57
18.23
33.81
8.95
% Of Sales
-
7.04%
6.27%
4.14%
4.61%
4.68%
4.85%
4.09%
5.53%
4.48%
Employee Cost
-
55.04
51.02
41.17
39.35
35.59
32.80
26.92
38.11
5.81
% Of Sales
-
10.54%
9.81%
7.31%
9.55%
7.66%
7.05%
6.04%
6.23%
2.91%
Manufacturing Exp.
-
22.03
25.80
16.28
14.89
13.29
12.14
10.35
37.94
7.31
% Of Sales
-
4.22%
4.96%
2.89%
3.61%
2.86%
2.61%
2.32%
6.20%
3.66%
General & Admin Exp.
-
12.78
15.32
14.93
8.05
8.69
8.45
9.00
10.51
3.36
% Of Sales
-
2.45%
2.95%
2.65%
1.95%
1.87%
1.82%
2.02%
1.72%
1.68%
Selling & Distn. Exp.
-
3.82
3.42
5.09
3.70
2.25
4.81
9.67
15.99
10.41
% Of Sales
-
0.73%
0.66%
0.90%
0.90%
0.48%
1.03%
2.17%
2.61%
5.21%
Miscellaneous Exp.
-
1.27
1.67
1.25
0.58
0.49
0.91
0.33
0.80
4.59
% Of Sales
-
0.24%
0.32%
0.22%
0.14%
0.11%
0.20%
0.07%
0.13%
2.30%
EBITDA
95.75
54.56
114.61
121.14
80.03
90.14
93.34
75.14
89.21
49.46
EBITDA Margin
15.95%
10.45%
22.05%
21.51%
19.43%
19.39%
20.08%
16.87%
14.59%
24.75%
Other Income
4.79
4.89
5.20
3.45
5.11
3.40
2.39
1.45
3.61
3.03
Interest
23.71
21.98
19.16
11.19
12.32
11.92
15.48
15.82
17.11
8.23
Depreciation
31.69
32.13
32.15
22.28
22.07
19.27
19.90
19.18
19.43
4.58
PBT
45.14
5.35
68.50
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Tax
10.94
1.47
0.62
30.16
18.07
20.90
19.89
5.97
14.63
14.20
Tax Rate
24.24%
27.48%
0.91%
33.10%
35.60%
33.52%
32.96%
14.36%
26.00%
35.80%
PAT
34.21
3.88
67.88
60.96
32.69
41.45
40.45
35.61
41.64
25.47
PAT before Minority Interest
34.21
3.88
67.88
60.96
32.69
41.45
40.45
35.61
41.64
25.47
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
5.70%
0.74%
13.06%
10.82%
7.94%
8.92%
8.70%
7.99%
6.81%
12.75%
PAT Growth
252.32%
-94.28%
11.35%
86.48%
-21.13%
2.47%
13.59%
-14.48%
63.49%
 
EPS
4.04
0.46
8.01
7.20
3.86
4.89
4.78
4.20
4.92
3.01

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Shareholder's Funds
460.53
470.29
410.53
348.24
321.92
284.49
254.74
293.60
192.08
Share Capital
8.47
8.47
8.47
8.47
8.47
8.47
8.47
8.47
10.00
Total Reserves
452.06
461.82
402.06
339.77
313.45
276.02
246.28
285.14
182.07
Non-Current Liabilities
164.17
192.73
206.26
114.47
94.35
96.58
91.41
161.56
88.21
Secured Loans
119.93
148.30
146.21
67.02
61.01
70.20
73.02
109.58
65.92
Unsecured Loans
1.20
1.20
1.20
1.20
1.20
1.20
1.20
3.64
6.95
Long Term Provisions
1.40
1.57
1.84
1.73
1.52
2.18
1.35
3.43
0.00
Current Liabilities
254.97
211.48
211.43
154.21
156.05
134.29
156.00
200.43
49.03
Trade Payables
113.15
72.86
65.44
44.49
47.70
39.27
66.75
84.40
23.86
Other Current Liabilities
46.93
54.69
58.31
38.84
23.32
22.91
19.95
40.37
0.33
Short Term Borrowings
93.79
67.91
70.86
61.16
70.81
58.40
59.76
72.75
0.00
Short Term Provisions
1.10
16.02
16.82
9.72
14.22
13.71
9.54
2.90
24.84
Total Liabilities
879.67
874.50
828.22
616.92
572.32
515.36
502.15
655.59
329.32
Net Block
412.02
437.99
457.36
280.49
281.26
279.26
290.45
370.35
68.84
Gross Block
575.55
569.62
558.80
360.77
339.57
318.34
309.63
500.81
96.16
Accumulated Depreciation
163.53
131.63
101.44
80.29
58.31
39.08
19.18
130.46
27.32
Non Current Assets
468.96
482.45
502.88
389.13
351.22
334.04
335.80
408.04
83.85
Capital Work in Progress
33.19
11.00
6.74
42.12
18.30
8.20
7.76
12.80
15.02
Non Current Investment
10.52
21.53
27.30
25.81
26.99
28.38
29.10
20.51
0.00
Long Term Loans & Adv.
10.70
9.32
9.10
38.47
22.55
16.19
6.58
4.37
0.00
Other Non Current Assets
2.54
2.61
2.38
2.25
2.13
2.01
1.90
0.00
0.00
Current Assets
410.70
392.05
325.33
227.78
221.09
181.32
166.36
247.55
233.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.03
Inventories
223.50
251.10
137.79
129.20
136.40
107.48
92.52
112.68
49.57
Sundry Debtors
148.35
48.52
105.68
48.77
26.02
24.15
21.32
61.09
59.98
Cash & Bank
7.47
46.66
40.51
9.65
14.88
12.71
12.37
15.08
95.71
Other Current Assets
31.39
6.39
19.18
20.96
43.79
36.98
40.15
58.70
28.60
Short Term Loans & Adv.
25.39
39.39
22.17
19.20
17.06
14.89
11.67
23.49
26.79
Net Current Assets
155.74
180.57
113.90
73.57
65.04
47.03
10.36
47.13
184.86
Total Assets
879.66
874.50
828.21
616.91
572.31
515.36
502.16
655.59
329.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Cash From Operating Activity
22.45
45.06
90.45
39.71
49.76
31.81
73.47
61.22
14.33
PBT
5.35
68.50
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Adjustment
52.99
49.86
27.76
28.66
26.81
31.08
31.58
28.14
18.09
Changes in Working Capital
-31.29
-58.38
-12.38
-27.60
-26.02
-48.48
9.40
-1.17
-29.61
Cash after chg. in Working capital
27.05
59.98
106.50
51.82
63.14
42.95
82.56
83.24
28.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.60
-14.92
-16.05
-12.10
-13.38
-11.14
-9.09
-22.02
-5.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-29.69
-27.15
-151.59
-42.56
-34.67
-16.58
-38.96
-96.72
-31.70
Net Fixed Assets
-28.12
-15.08
-162.65
-45.02
-31.33
-9.15
128.49
-346.44
Net Investments
-0.10
0.00
0.00
0.00
0.00
-8.02
-15.71
-17.94
Others
-1.47
-12.07
11.06
2.46
-3.34
0.59
-151.74
267.66
Cash from Financing Activity
-31.97
-11.75
92.02
-2.40
-12.92
-14.89
-33.19
44.34
106.55
Net Cash Inflow / Outflow
-39.20
6.16
30.88
-5.25
2.17
0.35
1.32
8.84
89.18
Opening Cash & Equivalents
46.58
40.42
9.54
14.80
12.63
12.29
11.25
2.41
6.53
Closing Cash & Equivalent
7.38
46.58
40.42
9.54
14.80
12.63
12.29
11.25
95.71

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Book Value (Rs.)
54.40
55.56
48.50
41.14
38.03
33.61
30.09
34.68
18.05
ROA
0.44%
7.97%
8.44%
5.50%
7.62%
7.95%
6.15%
8.46%
7.73%
ROE
0.83%
15.41%
16.07%
9.76%
13.67%
15.00%
12.99%
17.57%
14.11%
ROCE
3.79%
12.60%
17.62%
13.06%
16.57%
18.17%
12.73%
19.54%
18.91%
Fixed Asset Turnover
0.97
0.98
1.32
1.29
1.53
1.59
1.12
2.11
2.24
Receivable days
65.01
50.80
46.40
30.27
18.23
16.66
33.12
35.09
101.66
Inventory Days
156.71
128.12
80.21
107.49
88.61
73.28
82.47
47.02
84.02
Payable days
101.09
91.63
59.01
46.62
40.24
46.81
71.90
36.96
57.46
Cash Conversion Cycle
120.64
87.30
67.61
91.14
66.60
43.12
43.69
45.14
128.22
Total Debt/Equity
0.55
0.55
0.61
0.44
0.45
0.51
0.59
0.70
0.40
Interest Cover
1.24
4.57
9.14
5.12
6.23
4.90
3.63
4.29
5.82

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • SMS Pharmaceuticals - Quarterly Results
    8th Nov 2023, 13:05 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.